Tamsulosin Hydrochloride Capsule
Product Images NDC 72865-282

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 72865-282). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

100-0.4 mg (2)

100-0.4 mg (2)
Label for Tamsulosin Hydrochloride Capsules USP 0.4 mg by XL Care Pharmaceuticals Inc. The package contains 100 capsules with an oral dosage form. The label includes storage instructions, manufacturer details (Ascent Pharmaceuticals, Inc.), and a barcode. The product is Rx only and has a revision date of 09/24.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A line graph showing plasma concentration (ng/mL) of Tamsulosin Hydrochloride over time (hours). It compares the drug's concentration profile under fasted and fed conditions, illustrating differences in plasma levels up to 36 hours post-dose.*
FDA Label Image

Figure 2a (Figure 2a)

Figure 2a (Figure 2a)
A line graph displaying mean change over duration of treatment in weeks for three groups: 0.8 mg, 0.4 mg, and placebo. The x-axis shows treatment duration from baseline (B) to 13 weeks with LOCF, and the y-axis represents mean change, descending below zero. Data points include sample sizes per time point, showing decreasing mean values over time, with the 0.8 mg group showing the largest decline.*
FDA Label Image

Figure 2b (Figure 2b)

Figure 2b (Figure 2b)
A line graph showing mean change over time for three treatment groups: 0.8 mg, 0.4 mg, and placebo. The x-axis indicates time points with sample sizes (n) and the y-axis shows mean change values, depicting comparative responses for Tamsulosin Hydrochloride dosages versus placebo.*
FDA Label Image

Figure 3a (Figure 3a)

Figure 3a (Figure 3a)
A line graph illustrating mean change in mL/sec over treatment duration in weeks for three groups: 0.8 mg and 0.4 mg Tamsulosin Hydrochloride doses, and a placebo group. The y-axis represents mean change (mL/sec) ranging from 0 to 3, and the x-axis shows weeks of treatment from baseline (B) to 13 weeks, including a LOCF (last observation carried forward) point. Each group's progress is marked by distinct symbols: circles, triangles, and squares, respectively.*
FDA Label Image

Figure 3b (Figure 3b)

Figure 3b (Figure 3b)
A line graph showing mean change in mL/sec over duration of treatment in weeks for Tamsulosin Hydrochloride at 0.4 mg and 0.8 mg doses versus placebo. The graph includes sample sizes at intervals and tracks changes up to 13 weeks with last observation carried forward (LOCF), illustrating treatment effects over time.*
FDA Label Image

Structural (Stru)

Structural (Stru)
Chemical structure of Tamsulosin Hydrochloride, illustrating the molecular arrangement including aromatic rings, methoxy groups, amine, sulfonamide, and hydrochloride components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.